November 14, 2024
The global cardiometabolic disease market is undergoing significant growth, driven by the increasing prevalence of conditions such as obesity, diabetes, and cardiovascular diseases (CVD). The rising occurrence of these diseases, coupled with lifestyle factors such as sedentary living and an aging global population, is fostering demand for innovative treatments and management options. In 2023, the…